ChiCTR2300070988 版本V1.0 版本创建时间2023/04/27 17:46:03 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300070988 

最近更新日期:

Date of Last Refreshed on:

2023-04-27 17:45:33 

注册时间:

Date of Registration:

2023-04-27 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

连续性高频振荡治疗对机械通气患者肺通气的临床疗效观察

Public title:

Clinical efficacy of Continuous High-Frequency Oscillation Therapy on lung aeration in mechanically ventilated patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

连续性高频振荡治疗对机械通气患者肺通气的临床疗效观察

Scientific title:

Clinical efficacy of Continuous High-Frequency Oscillation Therapy on lung aeration in mechanically ventilated patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

胡正永 

研究负责人:

胡正永 

Applicant:

Hu Zhengyong 

Study leader:

Hu Zhengyong 

申请注册联系人电话:

Applicant telephone:

+86-15950469355

研究负责人电话:

Study leader's telephone:

+86-15950469355

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

624264057@qq.com

研究负责人电子邮件:

Study leader's E-mail:

624264057@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

南京市鼓楼区丁家桥87号

研究负责人通讯地址:

南京市鼓楼区丁家桥87号

Applicant address:

No. 87 Dingjiaqiao, Gulou District, Nanjing

Study leader's address:

No. 87 Dingjiaqiao, Gulou District, Nanjing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

东南大学附属中大医院

Applicant's institution:

Zhongda Hospital, Affiliated to Southeast University

研究负责人所在单位:

东南大学附属中大医院

Affiliation of the Leader:

Zhongda Hospital, Affiliated to Southeast University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023ZDSYLL108-P01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

东南大学附属中大医院临床研究伦理委员会

Name of the ethic committee:

IEC for Clinical Reasearch of Zhongda Hospital,Affiliated to Southeast University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-04-06 00:00:00

伦理委员会联系人:

王慧萍

Contact Name of the ethic committee:

Wang Huiping

伦理委员会联系地址:

南京市鼓楼区丁家桥87号

Contact Address of the ethic committee:

No. 87 Dingjiaqiao, Gulou District, Nanjing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 25 83272015

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

东南大学附属中大医院

Primary sponsor:

Zhongda Hospital, Affiliated to Southeast University

研究实施负责(组长)单位地址:

南京市鼓楼区丁家桥87号

Primary sponsor's address:

No. 87 Dingjiaqiao, Gulou District, Nanjing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

Country:

China

Province:

Jiangsu

City:

单位(医院):

东南大学附属中大医院

具体地址:

南京市鼓楼区丁家桥87号

Institution
hospital:

Zhongda Hospital, Affiliated to Southeast University

Address:

No. 87 Dingjiaqiao, Gulou District, Nanjing

经费或物资来源:

自筹

Source(s) of funding:

Self-funding

Target disease:

mechanical ventialtion

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究将通过临床实验研究方法,验证连续性高频振荡治疗对机械通气患者肺通气的影响,为其进一步推广应用提供科学可靠的理论研究基础。  

Objectives of Study:

This study will verify the effect of Continuous High-Frequency Oscillation Therapy on lung aeration in mechanically ventilated patients through clinical experimental research methods, and provide a scientific and reliable theoretical research basis for its further application.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.18-80岁;
2.GCS≤8分(言语反应为1分);
3.满足下列条件:体温<38.5℃,心率40-120次/分,收缩压90-180mmHg,和或舒张压≤110mmHg,平均动脉压≥65mmHg, ICP<20mmHg,腹内压<12mmHg,氧浓度FiO2<60%,呼吸频率≤35次/分,血氧饱和度≥90%;
4.机械通气≥24h,且预计继续通气时间≥1周;
5.签署知情同意书

Inclusion criteria

1. 18 to 80 years;
2. GCS ≤ 8 points (verbal response is 1 point);
3. the following criteria are met: body temperature <38.5°C, heart rate 40-120 beats/min, systolic blood pressure 90-180 mmHg, and or diastolic blood pressure ≤110 mmHg, mean arterial pressure ≥65 mmHg, ICP <20 mmHg, intra-abdominal pressure <12 mmHg, oxygen concentration FiO2 <60%, respiratory rate ≤35 breaths/min, oxygen saturation ≥90%;
4. mechanical ventilation ≥ 24h, and the expected duration of continued ventilation ≥ 1 week;
5. Signed informed consent form

排除标准:

1.BMI≥40kg/m2;
2.严重脊柱、胸廓畸形;
3.植入起搏器者;
4.躁动无法配合者;
5.已知或疑似膈肌失能如:膈神经断裂、神经肌肉疾病等;
6.未处理的张力性气胸;
7.肺出血;
8.怀孕;
9.符合入选标准,无排除标准>72h;
10.医疗团队认为其他不适合开展治疗的原因。

Exclusion criteria:

1. BMI ≥ 40 kg/m2;
2. severe spinal and thoracic deformities;
3. persons with implanted pacemakers;
4. those who are agitated and unable to cooperate;
5. known or suspected diaphragmatic dysfunction e.g. phrenic nerve rupture, neuromuscular disease, etc;
6. untreated tension pneumothorax;
7. pulmonary haemorrhage;
8. pregnancy;
9. meeting inclusion criteria without exclusion criteria >72h;
10. other reasons why the medical team considers it inappropriate to carry out the treatment.

研究实施时间:

Study execute time:

From 2023-04-28 00:00:00 To 2024-03-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-05-01 00:00:00 To 2024-02-28 00:00:00  

干预措施:

Interventions:

组别:

对照组

样本量:

37

Group:

Control group

Sample size:

干预措施:

常规干预

干预措施代码:

Intervention:

Routine interventions

Intervention code:

组别:

试验组

样本量:

37

Group:

Test group

Sample size:

干预措施:

常规干预和连续性高频振荡治疗

干预措施代码:

Intervention:

Routine interventions and Continuous High-Frequency Oscillation Therapy

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏省 

市(区县):

 

Country:

China 

Province:

Jiangsu 

City:

 

单位(医院):

东南大学附属中大医院 

单位级别:

三甲 

Institution
hospital:

Zhongda Hospital, Affiliated to Southeast University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肺通气

指标类型:

主要指标

Outcome:

lung aeration

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

膈神经运动传导

指标类型:

次要指标

Outcome:

Phrenic nerve motor conduction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

颤搐式膈肌移动度

指标类型:

次要指标

Outcome:

Twitchy diaphragm excursion

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

膈肌厚度

指标类型:

次要指标

Outcome:

Abdominal muscle thickness

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

咳嗽峰流速

指标类型:

次要指标

Outcome:

Cough peak flow

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

呼吸指标

指标类型:

次要指标

Outcome:

Respiratory index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肺部感染

指标类型:

次要指标

Outcome:

Lung infection

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

预后指标

指标类型:

次要指标

Outcome:

Prognostic Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

临床统计学家将符合入组标准的住院患者进行数字编号,采用随机数字表进行随机分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Clinical statisticians numbered inpatients who met the inclusion criteria and randomised them using a random number table.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

NONE

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

NO

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-04-27 17:45:33